Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Chlorophyllin Copper Sodium in Glioblastoma Multiforme: NCT06016452 Clinical Landscape Report 2026
16 October 2026
NCT06016452 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AT-0174 in Primary peritoneal carcinoma: ACTRN12623000956606 Clinical Landscape Report 2026
16 October 2026
ACTRN12623000956606 clinical landscape for Primary peritoneal carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Adagrasib in Pancreatic Ductal Adenocarcinoma: NCT06026410 Clinical Landscape Report 2026
16 October 2026
NCT06026410 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Carboplatin in Metastatic Triple-Negative Breast Carcinoma: NCT06027268 Clinical Landscape Report 2026
16 October 2026
NCT06027268 clinical landscape for Metastatic Triple-Negative Breast Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Cadonilimab in Renal Cell Carcinoma: NCT06035224 Clinical Landscape Report 2026
16 October 2026
NCT06035224 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in High grade B-cell lymphoma: NCT06026319 Clinical Landscape Report 2026
16 October 2026
NCT06026319 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tamoxifen Citrate in Breast Cancer: CTRI/2023/09/057359 Clinical Landscape Report 2026
16 October 2026
CTRI/2023/09/057359 clinical landscape for Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ADRX-0706 in Advanced Malignant Solid Neoplasm: NCT06036121 Clinical Landscape Report 2026
16 October 2026
NCT06036121 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Sunitinib Malate in Renal Cell Carcinoma: NCT06032728 Clinical Landscape Report 2026
16 October 2026
NCT06032728 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Hepatocellular Carcinoma: NCT06034860 Clinical Landscape Report 2026
16 October 2026
NCT06034860 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Diffuse large B-cell lymphoma refractory: NCT06033820 Clinical Landscape Report 2026
16 October 2026
NCT06033820 clinical landscape for Diffuse large B-cell lymphoma refractory: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Cisplatin in Ovarian Cancer: NCT06040970 Clinical Landscape Report 2026
16 October 2026
NCT06040970 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.